Your browser doesn't support javascript.
loading
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Thiel, Kristina W; Devor, Eric J; Filiaci, Virginia L; Mutch, David; Moxley, Katherine; Alvarez Secord, Angeles; Tewari, Krishnansu S; McDonald, Megan E; Mathews, Cara; Cosgrove, Casey; Dewdney, Summer; Aghajanian, Carol; Samuelson, Megan I; Lankes, Heather A; Soslow, Robert A; Leslie, Kimberly K.
Afiliação
  • Thiel KW; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.
  • Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.
  • Filiaci VL; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Mutch D; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO.
  • Moxley K; Stephenson Cancer Center, Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Alvarez Secord A; Duke University Institute, Duke University Health System, Durham, NC.
  • Tewari KS; University of California Irvine Medical Center, Irvine, CA.
  • McDonald ME; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.
  • Mathews C; Women and Infants Hospital in Rhode Island/The Warren Alpert Medical School of Brown University, Providence, RI.
  • Cosgrove C; Ohio State University Medical Center, James Cancer Hospital and Solove Research Institute, Obstetrics and Gynecology, Columbus, OH.
  • Dewdney S; Rush University Medical Center, Gynecology, Chicago, IL.
  • Aghajanian C; Memorial Sloan Kettering Cancer and Weill Cornell Medical Center, New York, NY.
  • Samuelson MI; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.
  • Lankes HA; Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH.
  • Soslow RA; The University of New Mexico Health Sciences Center, Albuquerque, NM.
  • Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.
J Clin Oncol ; 40(28): 3289-3300, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35658479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Neoplasias do Endométrio Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Neoplasias do Endométrio Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article